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Abstract
The study included rheumatoid arthritis patients from three regions of Uzbekistan, viz., Tashkent city - zone I (n=144), 
Khorezm region – zone II (n=112)  and the Namangan region – zone III (n=104). Comparative clinical and laboratory analyses 
showed the clear evidence of aggressive joint syndrome dominance in zone II (71.4%), which was higher than those of the patients 
in zone III (P<0.05), as well as the development of severe destructive lesions of the joints, even up to the joints ankylosing. Also, 
zone II was dominated by the visceral forms of the disease, up to 52.7%, whereas in zone I this value was 31.3%, while zone 
III was characterized by the low rates of extra-articular manifestations, at 11.5% (P<0.05). Moreover, the zone II patients in 
comparison with zone I patients more frequently required hospitalization and ambulant therapy (P<0.05). A retrospective study 
of the genetic aspects of rheumatoid arthritis patients had established the fact that in zone I, 52.14% of the patients’ family history 
was burdened with rheumatoid arthritis (28.6% in zone II and 24.1% in zone III); while in zone II - there was an upward trend in 
the incidence of the disease among the descendants of the rheumatoid arthritis patients, at 55.4% (27.8% in zone I and 23.1% in 
zone III). Thus, a comparative analysis demonstrated that the clinical and epidemiological parameters of rheumatoid arthritis were 
different in all the three areas of Uzbekistan, which did not exclude the probability of the influence of climatic and geographical 
factors on the course of the rheumatoid arthritis.
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Introduction
Rheumatic diseases (RD), in particular rheumatoid 
arthritis (RA) is one of the most common [1] and serious health 
as well as social problems, and therefore, is in the spotlight 
of not only health care managers, but also of physicians 
themselves. Despite the fact that the prognosis of RA has been 
constantly improved due to modern therapy, the morbidity and 
mortality rates remain highly substantial [2]. 
  However, by far, statistics do not reveal the true 
picture of the morbidity, because they consider mainly 
only the severe forms of the disease. Now, apparently, the 
organization of high quality care to the RA patients and 
preventive measures regarding the disease are impossible 
without the knowledge and consideration of the environmental 
factors and living conditions of the population. This, in turn, 
demonstrated the need to address the problem of using the 
experience drawn from many other fields of science, including 
medicine, ecology, demography, health and epidemiology. 
Over the recent years, importance is being increasingly paid 
to the area of residence of the patients, i.e. considering the 
impact of the climatic and geographical factors on the course 
of the disease. According to the literature data [2], the course 
of rheumatoid arthritis depends upon certain environmental 
factors, which also determines the further disease outcomes 
[3].  Therefore,  studying  the  influence  of  environmental 
factors is becoming increasingly essential to find a solution 
for the patients’ issues, which could help to identify a large 
group of cause-and-effect relationships, and spatial analysis 
of epidemiological phenomena [4]. Under the impact of 
the complex environmental factors, lesions are occurring 
in various organs and systems, accompanied by functional, 
morphological and genetic alterations as well, within the 
whole organism. Deterioration of the disease occurs under the 
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simultaneous influence of a myriad climatic and geographical 
factors, viz., solar radiation, atmospheric circulation and 
several local climatic features [5]. 
  Currently, Uzbekistan has become the focus of many 
medical and geographical studies because of the Republic’s 
distinctive geographical location, climatic factors and 
industrial as well as agricultural development. Moreover, 
special attention should be paid to the environmental problems 
in certain areas of the Republic. As it is known, deterioration 
in nature does not occur immediately or instantly. This process 
takes a much longer time. In other words, an environmental 
situation is normally one that is gradually accumulated. 
Uzbekistan’s biggest environmental challenge is the high 
degree of soil salinity. The real threat is the intensive soil 
pollution resulting from the various types of industrial and 
household wastes. One of the major problems is the water 
resource quality, an issue of the Aral Sea, while another 
threat for ecological security in the country is air and space 
pollution. For the Republic of Uzbekistan - located in the arid 
zone - the presence of large natural sources of atmospheric 
dust, such as the Kara-Kum and Kyzyl Kum deserts, with 
frequent dust storms, are characteristic. Therefore, we 
believe that this study is topical with regard to environmental 
rheumatology, particularly regarding the problem of RA in the 
various climatic and geographical zones of Uzbekistan. It is 
interesting for us to study the features of the development and 
the course of the RA in association with the environmental 
factors.
The purpose of this study was based on the comparative 
analysis of the clinical features of rheumatoid arthritis in a 
random sample of inhabitants of the various regions of 
Uzbekistan.
Material and Methods
A comparative analysis was conducted on the basis 
of a comparison of the clinical, radiological and laboratory 
findings in patients with RA, living in the different regions 
of the country. Disease activity and severity of the articular 
syndrome were determined by the number of tender and 
swollen joints,   DAS  (Disease activity score) and HAQ 
(Health Assessment Questionnaire) indexes and the evaluation 
of pain intensity, which were conducted according to VAS 
(Visual analog scale). Also, the following indicators were used 
for the analysis: the percentage of cases with positive clinical 
dynamics, the percentage of patients with long-term remission 
(more than 6 months), the percentage of patients requiring 
hospitalization, the percentage of frequently admitted patients 
(2 times or more per month in a year),  and the percentage of 
patients with comorbid conditions. 
The study included 360 patients with a valid diagnosis 
of RA, ranging in age from 20 to 66 years (mean age 51.58 ± 
8.2 years), with an illness duration of 9.7±4.8 years.
The studies were conducted in three regions of 
Uzbekistan, viz., Tashkent city - zone I (n=144), Khorezm 
region – zone II (n=112) and the Namangan region – zone III 
(n=104). 
In 25% of the patients, the I degree activity of the 
pathological process was ascertained; in 50% - II and in 25% - 
III. The I radiographic stage of RA is set to 9% of cases, II - in 
39%, III - in 30.5% and IV - in 19%.
Statistical analysis was performed using the statistical 
software «Statistica». The mean (M) and standard error of 
the mean (SEM) were deduced. Analysis of the distribution 
of values obtained was performed using the Kolmogorov-
Smirnov test. For data with normal distribution, significance 
was assessed using Student’s t-test corrected for multiple 
comparisons using Bonferroni criterion. A value of P<0.05 
was considered statistically significant.
Results and Discussion
Women were the dominant group among the patients 
observed, at 336 (93.3%). The disease duration ranged from 4 
months to 36 years (mean 9.7±4.8 years). Of these, 75 patients 
(20.8%) were ill for less than 5 years, 195 (54.2%) from 5 
to 10 years, and 90 patients (25%), for more than 10 years. 
Pharmacological remission was detected in 72 patients (20%); 
the current activity was being maintained in 288 patients 
(80%). Disability was detected in the majority (77.8% or 280 
patients) of patients and polyarthritis was documented in 355 
patients (98.6%). Systemic manifestations were observed in 
228 patients (63.3%). In addition to the main complaints, 
such as pain in the joints (98.6%) and morning stiffness 
(94.4%), the most frequent complaints were general weakness 
(62.5%), irritability, sleep and attention disorders (51.7%), 
restlessness and anxiety (63.9%), and subfebrile temperature 
(33.3%). Virtually all the patients with RA, regardless of the 
type of therapy, demonstrated signs of anemia and chronic 
inflammation.
The prospective studies conducted show that the course 
of the RA in the three different climatic and geographical 
zones reveals certain distinctions. Therefore, in zone II, there 
is certainly a dominance of a rapidly progressive start in 71.4% 
of the cases (in zone I – 24.3%, zone III - 18.3%). Moreover, 
as evident from Table 1, a more aggressive joint syndrome 
is characteristic for the patients in this zone. This trend is 
confirmed by the average values     of the number of swollen and 
tender joints in zone II patients, and among those of zone I 
as well, which are higher in number than those in zone III 
(P<0.05). While discussing the significance of these figures, it 
must be emphasized that the articular index of 28 joints and the 
degree of functional impairment of the joints (HAQ, Ritchie 
index) ended-up being very significant in the patients with 
RA in zone II in comparison with those in zone I (P<0.05). A 
comparative analysis of the laboratory and radiological data 
of the patients in the three zones highlighted some differences, 
especially in the patients between zones I and II, although 
the high activity of the disease  (by DAS index) is almost 
the same in those zones, at 72.2% and 80.4%, respectively. 
However, the development of severe destructive lesions of 
the joints until the total ankylosing was considerable in zone 
II, i.e. stage III radiological was detected in 49.1% and stage 
IV in 26.8% patients, whereas for zone I these figures were 
24.3% and 11.8%, respectively. Characterizing the articular 
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unlike those in the other zones, the presence of sacroiliitis was 
predominant in 21.2% of the cases. These experiments allow 
the determination of the predominant form of RA depending 
on the residence in a particular climatic zone and geographical 
area. As the research conducted reveals, in western Uzbekistan 
(zone II) the visceral form of the disease dominated, at 52.7%; 
in zone I it was 31.3%, while zone III was characterized by 
low rates of extra-articular manifestations, i.e. in 11.5% of the 
cases.
On comparison of these zones by assessing the extra-
articular manifestations (Table 2), it is important to note that 
there is an increase of nearly 4 times in the occurrence of 
systemic vasculitis, polyneuropathy and lymphadenopathy 
in zone II when compared with zone I (P<0.05), which is 
apparently connected with the presence of more environmental 
hazards in the Khorezm region.
 As far as the other extra-articular manifestations, such as 
subfebrile fever, weight loss, amyotrophy around the affected 
joints, the presence of rheumatoid nodes, heart disease, 
kidney  disease,  and  other  relevant  significant  differences 
between zones I and II, they were absent. The rheumatoid 
factor (especially with high titer) is of high diagnostic value, 
as its presence is the predictor of the systemic lesions in RA, 
because a significant majority of the seropositive patients, are 
from the western region-zone II (Table 1).
Valuable data on the predisposing factors among those 
patients with RA were extracted, as in zone I, and the rates 
of psycho-emotional stress were significantly more frequent, 
at 45.8% (9.6 % in zone II and 7.7 % in zone III), whereas 
the physical exertion figure was at 35.7% in zone II (10.4% 
in zone I and 8.7% in zone III). In turn, among the factors 
predisposing towards the development of the disease in zone 
III, hypothermia and acute respiratory infections were the 
dominant ones, at 66.3% (30.6 % in zone I and 26.8 % in zone 
II). 
By studying certain indicators, it has been revealed, as 
seen in Table 3, that among the zone II patients, the dominant 
factors were, the frequency of the need for hospitalization 
treatment, frequent visits to a doctor regarding the problems 
associated with the disease during one year, while in this 
region the long-term remission rates were low in comparison 
with the other zones. Besides, zone II dominated with such 
parameters as a tendency towards progression of the disease 
over the past three years (82.1%), and the manifestation of the 
disease at an early age, in 57.4% of the cases. In turn, zone 
III distinguished itself by the relatively low (positive) figures 
compared with the other zones.
 However, the data presented in Table 3 shows that in 
all the zones, in most patients, the manifestation of the disease 
was characterized by a gradual deterioration of the patient’s 
condition against the background of accompanying diseases.
A retrospective study of the genetic aspects of RA 
patients had established the fact that in zone I, 52.14% of 
the patients’ family history was burdened with rheumatoid 
arthritis (28.6% in zone II and 24.1% in zone III); while in 
zone II - there was an upward trend in the incidence of the 
disease among the descendants of the rheumatoid arthritis 
patients, at 55.4% (27.8% in zone I and 23.1% in zone III).
Table 1
The comparative analysis of clinical and laboratory parameters in 
patients with RA from various regions of Uzbekistan
Indicators
Zone I 
(n=144)
Zone II
(n=112)
Zone III 
(n=104)
Rheumatoid factor, U/l 105.6±24.3 551±23.5*” 93.6±4.5
Stiffness, hours 2.02±1.7 3.9±1.35” 1.01±1.8
Pain, VAS 6. 52±1.72ᶿ 7.75±1.52” 3.12±1.22
APJ 13.1±3.7ᶿ 19.3±8.5” 7.72±2.28
ASJ 7.6±1.86ᶿ 14.8 ±5.58*” 4.6 ±0.67
Ritchie index 7.65±3.03ᶿ 12.55±3.2” 4.54±1.1
VAS 55.32±16.6 67. 8±12.1” 33.31±13.2
Activity (Astapenko 
&Otto) 1.34±0.09 2.21±0.12” 0.77±0.24
Activity, SDAI 43.07±9.3 66.26±13.6” 35.06±7.46
HAQ 10.5±5.4 15.0±2.6” 7.5±1.94
CRP, mg/l 14.8±5.8ᶿ 27.9±8.43*” 7.07±0.1
ESR, mm/hour 30.3±14.67 31.4±13.69 29.3±12.67
*- p<0.05 between zones II and I; ᶿ- p<0.05 between zones I and III; 
« - p<0.05 between zones II and III. APJ – an amount of painful joints; 
ASJ – an amount of swollen joints; SDAI- the simplified disease activ-
ity index. 
Table 2
Comparative data on extra-articular manifestations of RA in 
various regions (results are shown in percentage)
Extra-articular 
manifestations
Zone I 
(n=144)
Zone II
(n=112)
Zone III 
(n=104)
Rheumatoid nodules 33.4 ᶿ 22.3” 8.7
Generalized amyotrophy 47.9 ᶿ 55.4” 9.6
Lymphadenopathy 14.9* 61.6” 10.6
Subfebrile fever 37.5ᶿ 58.9” 0
Hepatosplenomegaly 7.6 11.6 9.6
Sensitive polyneuropathy 8.3ᶿ* 32.1” 0
Systemic vasculitis 6.3ᶿ* 25.9” 0
Pleuritis (exudative) 0 0.9 0
Lung lesions 0.7 2.7 0
Kidney lesions 4.2ᶿ 6.3” 1.9
Heart lesions 10.4 8.9 7.7
Sjogren syndrome 1.4* 5.4” 0
Still’s syndrome 3.5 5.4” 0.9
 *- p<0.05 between zones II and I; ᶿ- p<0.05 between zones I and III; 
” - p<0.05 between zones II and III.
Table 3
Comparative data of indicators in patients with RA from various 
regions (results are shown in percentage)
Indicators
Zone I 
(n=144)
Zone II
(n=112)
Zone III 
(n=104)
Positive clinical changes 61.1 26.7*” 56.7
Long-term remission 40.3*ᶿ 18.8*” 59.6
Need hospitalization  31.3 50.0” 20.2
Frequently visiting a doctor      40.9ᶿ 68.8*” 27.9
Co-morbid conditions 61.1 67 52.9
*- p<0.05 between zones II and I; ᶿ- p<0.05 between zones I and III; 
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Conclusion
In conclusion, the retrospective analysis demonstrated 
that the clinical and epidemiological parameters of RA 
are different in all the three areas of Uzbekistan, which did 
not  exclude  the  probability  of  the  influence  of  climatic 
and geographical factors on the course of the disease. The 
comparative analysis of the genetically-effect relationships 
in the three zones of Uzbekistan allows the inclusion of the 
significant role played by the genetic alterations in the human 
organism due to environmental factors. The facts mentioned 
above call for a more focused and detailed study of the 
influence of the environmental factors on the development and 
progression of RA, which enables outlining the many possible 
ways to influence the progress of the disease, i.e. to develop a 
more rational basis for providing adequate therapies in order 
to improve the course of the disease and thus enhance the 
patient’s quality of life.
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